senate Bill S1877

Creates the bioscience facilities development program

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 13 / Jan / 2011
    • REFERRED TO CORPORATIONS, AUTHORITIES AND COMMISSIONS
  • 04 / Jan / 2012
    • REFERRED TO CORPORATIONS, AUTHORITIES AND COMMISSIONS

Summary

Creates the bioscience facilities development program; provides grants to local economic development corporations for the purpose of creating a revolving fund for loans to bioscience facilities to assist commercial bioscience companies to remain in New York state.

do you support this bill?

Bill Details

Versions:
S1877
Legislative Cycle:
2011-2012
Current Committee:
Senate Corporations, Authorities And Commissions
Law Section:
New York State Urban Development Corporation Act
Laws Affected:
Add ยง16-u, UDC Act
Versions Introduced in Previous Legislative Cycles:
2009-2010: S7228A
2007-2008: A4580A

Sponsor Memo

BILL NUMBER:S1877

TITLE OF BILL:
An act
to amend the New York state urban development corporation act, in
relation to creating the bioscience facilities development program

PURPOSE OF BILL:
To maximize the economic development potential of academic and
commercial bioscience activity throughout the State.

SUMMARY OF SPECIFIC PROVISIONS:
This bill establishes a new section 16-n in the urban development
corporation act creating a biofacilities development program
administered by local economic development corporations to establish
a revolving loan funds to provide loans to bioscience facilities to
assist commercial bioscience companies to remain in New York State.

Local economic development corporations must have firm commitments
from private and municipal sources of funding to provide funds to the
local economic development corporation in an amount at least equal to
the amount of the grants. It must also serve an economic development
region of the state as designated pursuant to section two hundred
thirty of the economic development law, which shall have colleges,
universities, hospitals, laboratories, and other research
institutions located within it.

Eligible borrowers include early and middle stage bioscience companies
with fewer than 200 employees and which have received funding from an
institutional venture capital firm. Use of funds is restricted to the
construction of laboratory and related space. The maximum size the
loan shall be no more than fifty percent of the cost of the
laboratory or related space.

JUSTIFICATION:
Biotechnology is an important economic development industry for the
state. The "Biotechnology Facilities Development Program" is designed
to overcome the critical impediment to the successful growth of a
biotech cluster in the New York State - access to affordable
laboratory space.

New York State has many assets that are critical to the growth of the
biotechnology industry including an extensive academic research base,
a highly skilled labor pool, access to financial institutions
oriented toward biotech development. However, even with many of the
critical elements for growing a biotechnology cluster New York can do
more to
foster development of its own regional biotechnology clusters through
addressing the critical need, identified and addressed successfully
in other states and other regions, for affordable laboratory space

PRIOR LEGISLATIVE HISTORY:
2003-04: A.10479
2005-06: A.4105
2007-08: A.4580A Referred to Rules


FISCAL IMPLICATIONS:
Undetermined.

EFFECTIVE DATE:
Immediate.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1877

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                            January 13, 2011
                               ___________

Introduced by Sen. ESPAILLAT -- read twice and ordered printed, and when
  printed  to be committed to the Committee on Corporations, Authorities
  and Commissions

AN ACT to amend the New York state urban development corporation act, in
  relation to creating the bioscience facilities development program

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Legislative  findings  and  declarations. The legislature
finds that New York state has many  assets  that  are  critical  to  the
growth of the biotechnology industry.
  The  legislature  also  finds  that  New  York  state has an extensive
academic research base, a highly skilled labor pool and access to finan-
cial institutions oriented toward biotech development.
  The legislature further finds that even  with  many  of  the  critical
elements  for  growing a biotechnology cluster, New York for all intents
and purposes has been eclipsed by a number of other regions in the coun-
try.
  Further, the legislature  finds  that  while  start-up  companies  are
established  in  New York, companies that are poised for rapid expansion
have left New York for regions that have developed vigorous biotech  and
policies  that deliberately invite, nurture and facilitate the expansion
of the industry and proactively address the biotech companies' need  for
affordable laboratory space.
  The  legislature  declares that biotechnology is an important economic
development industry for the state and that the critical  impediment  to
the  successful  growth of a biotech cluster in New York state is access
to  affordable  laboratory  space.  Therefore,  the  legislature  hereby
declares   the   creation  of  the  "bioscience  facilities  development
program".

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD06296-01-1

S. 1877                             2

  S 2. Section 1 of chapter 174 of the laws of 1968 constituting the New
York state urban development corporation act is amended by adding a  new
section 16-u to read as follows:
  S  16-U. THE BIOSCIENCE FACILITIES DEVELOPMENT PROGRAM. 1. THE BIOSCI-
ENCE FACILITIES DEVELOPMENT PROGRAM IS HEREBY CREATED  TO  MAXIMIZE  THE
ECONOMIC  DEVELOPMENT  POTENTIAL  OF  ACADEMIC AND COMMERCIAL BIOSCIENCE
ACTIVITY IN THE STATE, INCLUDING BUT NOT LIMITED TO BIOTECHNOLOGY, BIOM-
EDICINE, NANOMEDICINE, SPECIALTY PHARMACEUTICALS, MEDICAL  DEVICES,  AND
RELATED  SCIENCES,  IN  ORDER  TO BUILD UPON WORLD-RENOWNED RESEARCH AND
DEVELOPMENT ACTIVITIES IN THE BIOSCIENCES.
  2. (A) THE CORPORATION SHALL,  FROM  FUNDS  MADE  AVAILABLE  FOR  THIS
PURPOSE, PROVIDE GRANTS TO LOCAL ECONOMIC DEVELOPMENT CORPORATIONS WHICH
SERVE  A  REGION  MEETING THE CRITERIA SET FORTH IN SUBDIVISION THREE OF
THIS SECTION AND WHICH SHALL APPLY FOR SUCH GRANT IN A FORM  AND  MANNER
DETERMINED  BY  THE  CORPORATION FOR THE PURPOSE OF CREATING A REVOLVING
LOAN FUND TO PROVIDE LOANS TO BIOSCIENCE FACILITIES TO ASSIST INDIVIDUAL
COMMERCIAL BIOSCIENCE COMPANIES TO REMAIN IN NEW YORK STATE.
  (B) NO MORE THAN ONE LOCAL ECONOMIC DEVELOPMENT CORPORATION  SHALL  BE
SELECTED  FROM EACH ECONOMIC REGION OF THE STATE, AS DESIGNATED PURSUANT
TO SECTION 230 OF THE ECONOMIC DEVELOPMENT LAW, BY  THE  CORPORATION  TO
RECEIVE A GRANT PURSUANT TO THIS SECTION.
  3. A LOCAL ECONOMIC DEVELOPMENT CORPORATION APPLYING FOR A GRANT UNDER
THIS SECTION SHALL:
  (A)  HAVE  FIRM  COMMITMENTS  FROM  PRIVATE  AND  MUNICIPAL SOURCES TO
PROVIDE FUNDS TO THE LOCAL ECONOMIC DEVELOPMENT CORPORATION IN AN AMOUNT
AT LEAST EQUAL TO THE AMOUNT OF THE GRANT; AND
  (B) SERVE AN ECONOMIC DEVELOPMENT REGION OF THE  STATE  AS  DESIGNATED
PURSUANT  TO  SECTION  230 OF THE ECONOMIC DEVELOPMENT LAW, WHICH REGION
SHALL HAVE LOCATED WITHIN IT COLLEGES, UNIVERSITIES, HOSPITALS,  LABORA-
TORIES, AND OTHER RESEARCH INSTITUTIONS.
  4.  ELIGIBLE BORROWERS FROM THE FUND ESTABLISHED BY THE LOCAL ECONOMIC
DEVELOPMENT CORPORATION RECEIVING  A  GRANT  UNDER  THIS  PROGRAM  SHALL
INCLUDE  EARLY  AND  MIDDLE  STAGE BIOSCIENCE COMPANIES IN SUCH AREAS AS
BIOTECHNOLOGY, BIOMEDICINE, NANOMEDICINE, SPECIALTY PHARMACEUTICALS, AND
MEDICAL DEVICES, WITH FEWER THAN TWO HUNDRED EMPLOYEES  AND  WHICH  HAVE
RECEIVED FUNDING FROM AN INSTITUTIONAL VENTURE CAPITAL FIRM IN THE TWEN-
TY-FOUR  MONTHS PRIOR TO MAKING APPLICATION FOR A LOAN UNDER THIS SUBDI-
VISION, AND SHALL ALSO INCLUDE BOTH FOR-PROFIT AND NOT-FOR-PROFIT  PROP-
ERTY  OWNERS AND DEVELOPERS WHO ARE INTENDING TO DEVELOP AND LEASE SPACE
TO SUCH BIOSCIENCE COMPANIES, PROVIDED, HOWEVER, THAT THE  USE  OF  SUCH
FUNDS  IS RESTRICTED TO THE CONSTRUCTION OF LABORATORY AND RELATED SPACE
AND THAT THE MAXIMUM SIZE OF SUCH LOAN  SHALL  BE  NO  MORE  THAN  FIFTY
PERCENT  OF  THE  COST OF SUCH LABORATORY OR RELATED SPACE CONSTRUCTION.
SUCH LOANS UNDER THIS SUBDIVISION SHALL BE MADE FOR A PERIOD OF SEVEN TO
TEN YEARS AT A RATE OF SEVEN TO EIGHT PERCENT, EXCEPT THAT  DURING  SUCH
PERIOD  THAT  THE LOAN SHALL REMAIN OUTSTANDING, IF A BIOSCIENCE COMPANY
RECEIVING SUCH LOAN SHALL RELOCATE A SIGNIFICANT PORTION  OF  ITS  OPER-
ATIONS, AS DETERMINED IN A LOAN AGREEMENT WITH THE LOCAL ECONOMIC DEVEL-
OPMENT  CORPORATION,  OUTSIDE  NEW  YORK STATE, SUCH INTEREST RATE SHALL
RISE TO EIGHTEEN PERCENT ON A RETROACTIVE BASIS. IF, AFTER A  PERIOD  OF
FIVE YEARS FROM THE INCEPTION OF THE LOAN, A COMPANY SHALL REMAIN IN NEW
YORK  STATE,  TWENTY-FIVE  PERCENT  OF THE PRINCIPAL AMOUNT OF SUCH LOAN
SHALL BE FORGIVEN; AND IF AFTER A PERIOD OF TEN YEARS FROM THE INCEPTION
OF THE LOAN, A COMPANY SHALL REMAIN IN NEW YORK STATE, FIFTY PERCENT  OF
THE  PRINCIPAL  AMOUNT  OF SUCH LOAN SHALL BE FORGIVEN, FURTHER PROVIDED
THAT IF THE AMOUNT STILL OUTSTANDING ON THE LOAN SHALL BE LESS THAN  THE

S. 1877                             3

AMOUNT  FORGIVEN, THE DIFFERENCE SHALL BE REIMBURSED TO THE COMPANY. ANY
COMPANY RECEIVING SUCH A LOAN SHALL BE INDEPENDENTLY OWNED AND OPERATED.
FOR PURPOSES OF THIS SUBDIVISION,  THE  TERM  "INDEPENDENTLY  OWNED  AND
OPERATED  BUSINESS"  SHALL  MEAN  (A)  IN THE CASE OF A CORPORATION, ONE
WHERE NO MORE THAN FIFTY PERCENT OF THE VOTING STOCK OF THE  CORPORATION
IS OWNED OR CONTROLLED, DIRECTLY OR INDIRECTLY, BY A SINGLE CORPORATION,
A  SINGLE  PARTNERSHIP OR A SINGLE LIMITED LIABILITY COMPANY, AND (B) IN
THE CASE OF A PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY, WHERE  NO  MORE
THAN  FIFTY PERCENT OF THE CAPITAL, PROFITS OR OTHER BENEFICIAL INTEREST
IN SUCH PARTNERSHIP, ASSOCIATION OR OTHER ENTITY IS OWNED OR CONTROLLED,
DIRECTLY OR INDIRECTLY, BY A SINGLE CORPORATION, A SINGLE PARTNERSHIP OR
A SINGLE LIMITED LIABILITY COMPANY.
  5. GRANTS RECEIVED FROM THE CORPORATION BY A LOCAL  ECONOMIC  DEVELOP-
MENT  CORPORATION, EARNINGS ON SUCH MONIES, AND ANY PRINCIPAL REPAYMENTS
AND ANY INTEREST EARNED ON LOANS SHALL  BE  DEPOSITED  IN  A  LOAN  FUND
ACCOUNT.
  6.  THE  DECISION  TO  APPROVE  OR REJECT AN APPLICATION FOR FINANCIAL
ASSISTANCE PURSUANT TO THE PROVISIONS OF THIS SECTION SHALL BE MADE BY A
MAJORITY OF THE DIRECTORS OF THE LOCAL ECONOMIC DEVELOPMENT CORPORATION,
AND SUCH DECISION SHALL BE FINAL.  NO  MEMBER  OF  THE  BOARD  OR  OTHER
GOVERNING  BODY  OF  THE  LOCAL  ECONOMIC  DEVELOPMENT CORPORATION SHALL
PARTICIPATE IN A DECISION ON A PROJECT APPLICATION WHEN SUCH MEMBER IS A
PARTY TO OR HAS A FINANCIAL INTEREST IN SUCH  PROJECT.  ANY  MEMBER  WHO
CANNOT  PARTICIPATE  IN  A  DECISION  ON  A PROJECT APPLICATION FOR SUCH
REASON SHALL NOT BE COUNTED AS A MEMBER OF THE BOARD OR OTHER  GOVERNING
BODY  FOR  PURPOSES  OF DETERMINING THE NUMBER OF MEMBERS REQUIRED FOR A
MAJORITY VOTE ON SUCH APPLICATION. NO EMPLOYEE OR OFFICER  OF  ANY  SUCH
CORPORATION  SHALL  BE  A PARTY TO OR HAVE ANY FINANCIAL INTEREST IN ANY
PROJECT THAT RECEIVES FINANCIAL ASSISTANCE PURSUANT TO THIS SECTION.
  7. THE CORPORATION MAY WITHDRAW ANY AMOUNT REMAINING FROM AN  ORIGINAL
GRANT  AND  ANY EARNINGS ON SUCH GRANT, AND ANY PRINCIPAL REPAYMENTS AND
ANY INTEREST EARNED ON LOANS MADE FROM SUCH GRANT WHEN  A  MEMBER  OF  A
BOARD  OF  DIRECTORS,  AN  OFFICER OR AN EMPLOYEE OF SAID CORPORATION IS
PARTY TO OR HAS FINANCIAL INTERESTS IN LOAN PROJECTS;  WHEN  SAID  LOCAL
ECONOMIC  DEVELOPMENT  CORPORATION FAILS TO COMPLY WITH THE REQUIREMENTS
FOR PROJECT LOANS PURSUANT TO THIS SECTION;  OR  WHEN  SAID  CORPORATION
MAKES  NO  LOANS  WITHIN THE PREVIOUS FISCAL YEAR. OUTSTANDING LOANS AND
OTHER OBLIGATIONS PAYABLE TO SUCH LOCAL ECONOMIC DEVELOPMENT CORPORATION
SHALL BE ASSIGNED TO THE CORPORATION UPON SUCH TERMS AND  CONDITIONS  AS
THE CORPORATION SHALL DETERMINE.
  8. THE LOCAL ECONOMIC DEVELOPMENT CORPORATION RECEIVING A GRANT PURSU-
ANT  TO THIS SECTION SHALL SUBMIT ANNUAL REPORTS FOR THE PREVIOUS FISCAL
YEAR TO THE CORPORATION DESCRIBING  THE  FINANCIAL  ASSISTANCE  PROVIDED
PURSUANT  TO  THIS  SECTION, INCLUDING: THE NUMBER OF PROJECTS ASSISTED;
THE AMOUNT AND  TYPE  OF  ASSISTANCE  PROVIDED;  A  DESCRIPTION  OF  THE
PROJECTS;  THE  NUMBER  OF  JOBS  CREATED  OR  RETAINED;  THE  STATUS OF
OUTSTANDING LOANS, GUARANTEES, EARNINGS AND ACCOUNT BALANCES;  AND  SUCH
OTHER INFORMATION AS THE CORPORATION MAY REQUIRE.
  9.  THE  CORPORATION  SHALL  ANNUALLY  CONDUCT  AN AUDIT OF EACH LOCAL
ECONOMIC DEVELOPMENT CORPORATION RECEIVING A GRANT TO ENSURE  CONFORMITY
OF  ALL  ASPECTS  OF  PROGRAM ADMINISTRATION AND OF FINANCIAL ASSISTANCE
TRANSACTIONS WITH THE SUBSTANTIVE  AND  PROCEDURAL  PROVISIONS  OF  THIS
SECTION.  IN  THE EVENT THAT THE CORPORATION FINDS INSTANCES OF SUBSTAN-
TIVE NONCOMPLIANCE BY AN ECONOMIC DEVELOPMENT CORPORATION  WITH  ANY  OF
THE  PROVISIONS  OF THIS SECTION AND SUCH INSTANCES WERE, OR SHOULD HAVE
BEEN, KNOWN TO BE IN NONCOMPLIANCE, THE ECONOMIC DEVELOPMENT CORPORATION

S. 1877                             4

SHALL RETURN, WITHIN THIRTY DAYS, UPON DEMAND BY  THE  CORPORATION,  ALL
UNCOMMITTED  GRANT  FUNDS  ON  HAND  AND PROVIDE AN ACCOUNT OF THE LOANS
CURRENTLY OUTSTANDING.
  10. THE CORPORATION SHALL, ON OR BEFORE OCTOBER FIRST OF THE YEAR NEXT
SUCCEEDING  THE  EFFECTIVE  DATE  OF THIS SECTION, AND ON OR BEFORE EACH
OCTOBER FIRST THEREAFTER, SUBMIT A REPORT TO THE GOVERNOR AND THE LEGIS-
LATURE ON THE OPERATIONS AND ACCOMPLISHMENTS OF THE  BIOSCIENCE  FACILI-
TIES  DEVELOPMENT  PROGRAM.  SUCH  REPORT SHALL INCLUDE A SUMMARY OF THE
INFORMATION CONTAINED IN THE REPORTS SUBMITTED PURSUANT  TO  SUBDIVISION
EIGHT  OF THIS SECTION AND OF THE RESULTS OF THE AUDITS PERFORMED BY THE
CORPORATION PURSUANT TO SUBDIVISION NINE OF THIS SECTION, AND SHALL  SET
FORTH  THE  STATUS  OF  THE  BIOSCIENCE  FACILITIES  DEVELOPMENT PROGRAM
REVOLVING LOAN PROGRAM FOR THE PREVIOUS FISCAL YEAR.
  S 3. This act shall take effect immediately.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.